Allied Market Research
Upcoming Allied Market Research
Adrenergic Drug Market

Adrenergic Drug Market: Global Opportunity Analysis and Industry Forecast, 2020-2030

Pages: NA
Feb 2022 | 485 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Adrenergic Drug Market

Request Now !

Adrenergic drugs, also named as sympathomimetic drugs stimulate a response from the adrenergic receptors. This drug is used to stimulate the sympathetic nervous system located in the chest and lower back region of the spinal cord. These drugs stimulate the chemical messenger epinephrine and norepinephrine from the adrenal gland, or replicate the action of these chemical messengers. There are five main categories of adrenergic receptors as α₁, α₂, β₁, β₂, and β₃. Adrenergic drugs are used to increase the breathing rate, heartbeat, sweating, urine flow, and prevent bleeding. There are three major types of adrenergic drugs most commonly used such as Bronchodilators, vasopressors, and cardiac stimulators. This drug is used in the treatment of various life-threatening conditions including chronic obstructive pulmonary diseases (COPD), asthma, cardiac arrest, shock, and allergic reactions. 


Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value ($USD)

  Segments covered

Drug Class, Route of Administration, Disease Indication, Distribution Channel

  Region covered

North America (U.S., and Canada), Europe (U.K, France, Italy, Spain Belgium, Netherlands, Luxembourg, and Rest of Europe), Asia-Pacific (China, India, Japan, New Zealand, and Rest of Asia-Pacific), LANTAM (Brazil, Mexico, Peru, Chile, and Rest of Latin America), Middle East & Africa (South Africa, North Africa, and UAE)

  Companies covered

Major players analyzed include, Boehringer Ingelheim GmbH, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., AstraZeneca plc., GlaxoSmithKline plc., Novartis AG, Pfizer Inc., Mylan Pharmaceutical Inc., Cipla, Bayer, Impax Generics.


COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. 

As the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries across the globe with the “World Health Organization” announcing it a public health emergency. The global impacts of the COVID-19 pandemic are already starting to be felt, and will significantly affect the adrenergic drug market in 2020. COVID-19 can affect the global economy in three main ways by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America holds the largest market share and dominates the adrenergic drug market. This is attributed to factors such as growing patient population, increasing product launches, presence of major market player and increasing chronic disorder associated patient population. However, Europe accounts for the second largest share in the adrenergic drug market. This is due to increase in product approvals, rise in awareness, adoption of expansion strategies by global manufacturers and strategic acquisition of manufacturers as well as increase in R&D activities. Whereas, Asia-Pacific is expected to witness the highest adrenergic drug market growth rate. This is due to large number of patient diagnosed with asthma and COPD, rising healthcare expenditure, and increasing healthcare facilities 

“WHO” reported that, in 2017, around 251 million individuals were affected by chronic obstructive pulmonary disease across the globe. “American Heart Association” (AHA) reported that globally, around 350,000 cases of cardiac arrest are reported at hospital set ups every year. 

Factors that drive the growth of the adrenergic drug market include increasing new product development, rising incidences of chronic obstructive pulmonary diseases (COPD), asthma, and cardiac arrest, increasing patient population, rising applications of adrenergic drugs for a variety of disease indications, technological advancements, increase in incidence of chronic diseases, rising awareness among the individuals regarding timely diagnosis, rise in strategic collaborations, and rising products approvals by regulatory authorities.  However, factors that restrain the growth of  adrenergic drug market include side effects of adrenergic drugs includes irregular heartbeat, high blood pressure as well as chest pain and high cost of product development. The opportunities available for adrenergic drug market such as reduction in the cost of adrenergic drug product, introducing advanced product with less or no side effect 

New Product launch to flourish the market:

Major Key manufacturers have been focusing on increasing R&D activities and producing new product solution for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications.  In 2019, “Boehringer Ingelheim GmbH” has launched “StioltoTM Respimat ® Inhalation Spray” is a prescription medicine used for long term, two puffs every day, in controlling symptoms in adults with chronic obstructive pulmonary disease (COPD). COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. 

In 2018, “Merck & Co., Inc.” has launched a new adrenergic product such as “L-798106”. This was among the first prostanoid receptor EP3-selective antagonists. It has been used in multiple studies to tease out EP3 agonist activity, both in vitro and in vivo. It successfully blocks the actions of sulprostone, an EP3-selective agonist, and it helped show that the vascular contraction effect of PGE2 is due to its prostanoid EP3 agonist activity. 

In 2018, “Teva Pharmaceutical” has launched “ AIRDUO® DIGIHALER™” is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older. 

Key segments covered:



  Drug Class

· Bronchodilators

· Vasopressors

. Catecholamine’s

. Others

  Route of Administration

· Oral Route

· Intravenous Route

· Inhalation

  Disease Indication

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

· Bronchitis

· Cardiac Arrest

· Shock

· Others

  Distribution Channel

· Hospital Pharmacy

· Retail Pharmacy

· E-Commerce


Key benefits of the report:

  • This study presents the analytical depiction of the global adrenergic drug market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global adrenergic drug market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global adrenergic drug market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global adrenergic drug market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Adrenergic Drug Market research report:

  • Who are the leading market players active in adrenergic drug market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Adrenergic Drug Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers